A 14-year-old male developed severe myocarditis complicated by cardiogenic shock 10 days after receiving an mRNA COVID-19 vaccine, which was successfully managed with vasoactive drugs and corticosteroids.
Case Report (n=1)
Does mRNA COVID-19 vaccination cause myocarditis and cardiogenic shock in adolescents?
This case report highlights the rare but severe risk of fulminant myocarditis and cardiogenic shock following mRNA COVID-19 vaccination in adolescents, emphasizing the need for monitoring.
INTRODUCTION: and importance: After its unexpected effectiveness in the clinical trials, the anti-COVID-19 vaccine type mRNA was launched on December 11, 2020, but a few months later, several reports of post-mRNA vaccination myocarditis were published, but without any proven causal link. CASE PRESENTATION: We report the case of a 14-year-old teenager admitted to the emergency department for a cardiogenic shock, the patient mentioned that he had an anti-COVID 19 vaccination 10 days before his admission. First, the vasoactive drugs had stabilized the patient; the troponins came back highly favorable but later confirmed myocarditis by magnetic resonance imaging. In this sense an etiological analysis was made and it came back without any particularities, leaving us relating the myocarditis to the vaccination. CLINICAL DISCUSSION: Post-vaccination myocarditis is a rare event, with very few reports in the literature. After the introduction of COVID vaccination, several reports were published, mostly after the mRNA vaccine. Until now, no causal link has been proven, so we need to have more reports in this sense to have a better knowledge of this phenomenon. CONCLUSION: Until we obtain a more precise explanation of the mechanism of myocarditis after vaccination with the anti-COVID-19 vaccine, all symptoms suggesting myocarditis should be systematically monitored during the first 7 days after vaccination.
Mimouni et al. (Thu,) conducted a case report in Myocarditis complicated by cardiogenic shock (n=1). mRNA COVID-19 vaccine was evaluated on Development of myocarditis and cardiogenic shock. A 14-year-old male developed severe myocarditis complicated by cardiogenic shock 10 days after receiving an mRNA COVID-19 vaccine, which was successfully managed with vasoactive drugs and corticosteroids.